Equity - Schedule of Warrant Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Total Warrants
Outstanding at the beginning	9,305,790	3,075,470
Issued	8,215,963	6,193,449
Assumed		3,586,250
Exercised		(3,330,956)
Forfeited		(218,423)
Expired	(1,036,830)
Outstanding at the end	16,484,923	9,305,790	3,075,470
Weighted Average Remaining Term
Outstanding	3 years 7 months 2 days	3 years 7 months 13 days	4 years 4 months 2 days
Issued (in years)	5 years 6 months	1 year 10 months 24 days
Assumed (in years)		5 years
Expired (Years)	2 years 7 months 13 days
Weighted Average Exercise Price
Outstanding at the beginning (in dollars per share)	$ 9.09	$ 1.09
Issued (in dollars per share)	3.11	4.62
Exercised (in dollars per share)		(3.19)
Forfeited (in dollars per share)		(1.53)
Expired (in dollars per share)	(3.05)
Assumed (in dollars per share)		(11.50)
Outstanding at the end (in dollars per share)	$ 6.49	$ 9.09	$ 1.09
Aggregate Intrinsic Value
Outstanding at the beginning (in dollars)	$ 4,942	$ 150,956
Issued (in dollars)		115,941
Assumed (in dollars)		45,725
Exercised (in dollars)		(67,412)
Forfeited (in dollars)		(1,501)
Outstanding at the end (in dollars)		$ 4,942	$ 150,956
Substitute Warrants
Weighted Average Exercise Price
Outstanding at the beginning (in dollars per share)	$ 2.45
Outstanding at the end (in dollars per share)		$ 2.45
Public Warrants
Total Warrants
Exercised	0	(1,144)
Outstanding at the end	3,450,000
Weighted Average Exercise Price
Outstanding at the end (in dollars per share)	$ 11.50
Placement Warrants
Total Warrants
Outstanding at the end	136,250
As previously reported
Total Warrants
Outstanding at the beginning		620,055
Outstanding at the end			620,055
Weighted Average Remaining Term
Outstanding			11 years 29 days
Weighted Average Exercise Price
Outstanding at the beginning (as previously reported) (in dollars per share)			$ 14.61
Aggregate Intrinsic Value
Outstanding at the beginning (as previously reported) (in dollars)			$ 22,128
Retroactive application of reverse recapitalization
Total Warrants
Outstanding at the beginning		2,455,415
Outstanding at the end			2,455,415
Weighted Average Exercise Price
Retroactive application of reverse recapitalization (in dollars per share)			$ (13.53)